SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-239983
Filing Date
2023-09-22
Accepted
2023-09-22 06:05:01
Documents
15
Period of Report
2023-09-22
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d558859d8k.htm   iXBRL 8-K 23722
2 EX-99.1 d558859dex991.htm EX-99.1 57817
6 GRAPHIC g558859dsp1aa.jpg GRAPHIC 9009
7 GRAPHIC g558859dsp1ab.jpg GRAPHIC 7003
  Complete submission text file 0001193125-23-239983.txt   238356

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA sgen-20230922.xsd EX-101.SCH 2875
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE sgen-20230922_lab.xml EX-101.LAB 17236
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sgen-20230922_pre.xml EX-101.PRE 10829
9 EXTRACTED XBRL INSTANCE DOCUMENT d558859d8k_htm.xml XML 3203
Mailing Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021
Business Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021 4255274000
Seagen Inc. (Filer) CIK: 0001060736 (see all company filings)

IRS No.: 911874389 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-32405 | Film No.: 231270188
SIC: 2836 Biological Products, (No Diagnostic Substances)